Bottom line
DLHAX vs PHSYX: the short answer
DLHAX (Nomura Healthcare Fund) and PHSYX (Putnam Global Health Care Fund) are both mutual funds.
PHSYX is cheaper at 0.79% vs 1.21% — a difference of $42 a year per $10,000 invested.
Over five years, PHSYX returned +8.1% a year vs +6.2% for DLHAX (reporting dates differ).
DLHAX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
DLHAX vs PHSYX side by side
| DLHAX | PHSYX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Voya | Franklin Templeton |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.21% | 0.79% |
| Annual cost per $10k | $121 | $79 |
| 10-yr cost on $10k (prospectus) | $2,006 | $978 |
| Max front load | 5.75% | 0% |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +15.1% | +1.5% |
| 5-yr return (annualized) | +6.2% | +8.1% |
| 10-yr return (annualized) | +9.5% | +7.8% |
| Best quarter | +21.5% | — |
| Worst quarter | −14.9% | — |
| Net assets (fund) | $750.2M | $1.5B |
| Number of holdings | 108 | 115 |
| Portfolio turnover | 4% | 67% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
10 of DLHAX's top 25 holdings also appear in PHSYX's top 25.
| Holding | DLHAX | PHSYX |
|---|---|---|
| Abbvie Inc | 4.19% | 6.05% |
| Eli Lilly & Company | 4.16% | 13.15% |
| Unitedhealth Group Inc | 3.88% | 6.93% |
| Merck & Company Inc | 3.68% | 4.88% |
| Gilead Sciences Inc | 3.54% | 2.63% |
| Astrazeneca Plc | 3.27% | 4.67% |
| Roche Holding Ag | 3.01% | 2.79% |
| Amgen Inc | 2.27% | 1.11% |
| Vertex Pharmaceuticals Inc | 1.66% | 1.97% |
| Boston Scientific Corp | 1.42% | 1.80% |
Source: SEC Form N-PORT
DLHAX top 10
- Ucb Sa — 5.19%
- Abbvie Inc — 4.19%
- Eli Lilly & Company — 4.16%
- Regeneron Pharmaceuticals Inc — 3.91%
- Unitedhealth Group Inc — 3.88%
- Pfizer Inc — 3.84%
- Merck & Company Inc — 3.68%
- Gilead Sciences Inc — 3.54%
- Astrazeneca Plc — 3.27%
- Elevance Health Inc — 3.25%
PHSYX top 10
- Eli Lilly & Co. — 13.15%
- Johnson & Johnson — 8.46%
- UnitedHealth Group, Inc. — 6.93%
- AbbVie, Inc. — 6.05%
- Novartis AG — 5.13%
- Merck & Co., Inc. — 4.88%
- AstraZeneca plc — 4.67%
- Thermo Fisher Scientific, Inc. — 4.50%
- Intuitive Surgical, Inc. — 4.04%
- Sanofi SA — 3.23%
FAQ
What is the difference between DLHAX and PHSYX?
Which is cheaper, DLHAX or PHSYX?
Should I own both DLHAX and PHSYX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.